Sanara MedTech (SMTI) Share-based Compensation (2010 - 2026)
Sanara MedTech's (SMTI) quarterly Share-based Compensation came in at $9.1 million in Q1 2026, up 596.47% YoY from $1.3 million in Q1 2025, and up 686.49% on a QoQ basis from $1.2 million in Q4 2025.
Sanara MedTech (SMTI) Share-based Compensation (2010 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 15 years of Share-based Compensation data on file, last reported at $9.1 million in Q1 2026.
- Quarterly Share-based Compensation rose 596.47% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 1024.11% YoY) and the FY2025 annual result came in at $5.7 million, up 35.89% from the prior year.
- Share-based Compensation improved to $9.1 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $13.8 million in Q4 2022 to a low of -$2.9 million in Q4 2024.
- A 5-year average of $2.0 million and a median of $1.1 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation jumped 657.82% — and 2024, when it sank 924.63%.
- Tracing SMTI's Share-based Compensation over 5 years: stood at $13.8 million in 2022, then sank by 97.44% to $353077.0 in 2023, then slumped by 924.63% to -$2.9 million in 2024, then soared by 139.69% to $1.2 million in 2025, then soared by 686.49% to $9.1 million in 2026.
- The last three Share-based Compensation figures came in at $9.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.09 Mn |
| Mar 31, 2026 | 9.09 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 803,386.00 |
| Mar 31, 2024 | 803,386.00 |
| Dec 31, 2023 | 353,077.00 |
| Dec 31, 2023 | 353,077.00 |